Drug intelligence / Profile preview

WYHZ formula

Development stage: Preclinical
Lead developer: young qihuang scholars support project
Administration: Oral

Overview

WYHZ formula is a Traditional Chinese Medicine (TCM) formula being investigated for its clinical efficacy on the maternal-fetal interface microenvironment and embryo implantation in patients with chronic endometritis combined with recurrent implantation failure. Its name, "温阳化浊方" (Warming Yang and Resolving Turbidity Formula), indicates its therapeutic approach is based on balancing "Yang" energy and clearing "turbidity" according to traditional Chinese medicine principles.

Other names: 温阳化浊方

Beyond the preview

Go deeper on WYHZ formula.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on WYHZ formula.

Explore the full profile